Bioverse
$259from-price, “/mo”
- Delivery
- SubQ
- Price source
- September 2026
Recorded NAD+ price
$93from-price, “Per month”; from-price, “/mo”
We may earn a commission if you buy through this link.
Check CoreAge Rx pricesCoreAge Rx displays both NAD+ nasal spray and injectable treatment from $93 per month. Their matching starting prices do not establish matching quantities, and the injection description allows either intramuscular or subcutaneous administration.
See the recorded offersThe dedicated nasal and injectable pages each show a $93 monthly starting figure; each also links to the other product at the same starting amount. Those cross-sell cards are repeated observations of the products, not four independent plans. Neither dedicated page ties the price to a stated concentration, vial or bottle volume, or a defined number of doses.
The injectable description explicitly says intramuscular or subcutaneous. We therefore leave its single-route comparison field unspecified rather than declaring that the advertised price is exclusively subcutaneous. Confirm the prescribed route and supplied quantity. The page’s claims about potency and treatment benefits are seller claims, not evidence that the injection is clinically superior to the nasal product.
The product pages advertise no membership fees, no long-term contracts and free delivery. The policy qualifies standard shipping as included on prescription orders unless otherwise disclosed at checkout. It also says both one-time purchases and automatically renewing plans may be offered. Confirm which purchase type applies to your $93 starting quote and when the next charge would occur.
Match the amount to its payment terms and product. Starting prices, introductory offers and prepaid totals are different commitments.
| Price | Payment terms | Delivery and quantity |
|---|---|---|
| $93 | Starting price“Per month” | Nasaldose not stated |
| $93 | Starting price“/mo” | not stateddose not stated |
| $93 | Starting price“Per month” | not stateddose not stated |
| $93 | Starting price“/mo” | Nasaldose not stated |
We may earn a commission if you buy through this link.
Compare the payment conditions and dated prices, then read each full review. These are options to investigate, not a judgment of clinical quality.
from-price, “/mo”
from-price, “/month”
from-price, “/month”
from-price, “(used daily)”; from-price, “/month”
The current comparison uses observations dated October 2026. Earlier observations remain separate from current offers.
These are earlier observations, not current offers. Use the current prices and plan terms above when comparing a purchase.
Starting at $93 Per month
Read September 2026 · Visible on the source pageNAD+ Injectable Starting at $93/mo
Read September 2026 · Visible on the source pageStarting at $93 Per month
Read September 2026 · Visible on the source pageNAD+ Nasal Starting at $93/mo
Read September 2026 · Visible on the source pageReading dates record when an offer was checked, not a guarantee of today’s price. Confirm the current product, supply and payment terms before ordering.
This score measures the clarity of published price information. It does not rate the product, clinician, treatment quality or value for money.
Swipe or scroll to see all scoring details.
| What is scored | What CoreAge Rx publishes | Points |
|---|---|---|
| An exact figure | The published figure is a floor — a “from” or “starting at” number, which is the bottom of a range and not necessarily a price anyone is charged. | 6of 30 |
| A stated cadence | The seller states the interval it bills on, so a reader knows when the next charge lands. | 20of 20 |
| Visible on the page | Every headline figure (4 figures) is printed where a reader can see it. | 20of 20 |
| A stated route | The seller states how the product is administered, in its own sentence. | 15of 15 |
| A stated dose | None of this seller's 4 figures states a dose, so no cost per milligram can be worked out from the page. | 0of 15 |
| Price disclosure score | This scores what the seller publishes about its price — not the product, the clinic, the prescriber or the value. | 61of 100 |